A novel spray-drying technology to improve the bioavailability of biopharmaceutical classification system class II molecules

Drug Development and Delivery

Volumn 12, Issue 1, 2012, Pages 26-31

  Shi, David ^a   Loxley, Andrew ^b   Lee, Robert W ^b   Fairhurst, David ^b  

^a Particles Sciences Inc ^*

^b Particle Sciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; EXCIPIENT; IBUPROFEN; POLYMER; RESVERATROL;

AREA UNDER THE CURVE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DUODENUM; HUMAN; NOTE; PHYSICAL CHEMISTRY; SPRAY DRYING; X RAY DIFFRACTION;

EID: 84855932406     PISSN: 15372898     EISSN: 1944818X     Source Type: Trade Journal    
DOI: None     Document Type: Note

References (14)

1. Chen ML, Amidon GL, Benet LZ, Lennernas H, Yu LX. The BCS, BDDCS, and regulatory guidances. Pharm Res. 2011;28:2774.
2. Yu LX, Amidon GL, Polli JE, Zhao H, Mehta MU, Conner DP, Shah VP, Lesko LJ, Chen ML, Lee VH, Hussain AS. Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm Res. 2002;19:921.
3. Takagi T, Ramachandran C, Bermejo M, Yamashita S, Yu LX, Amidon GL. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol Pharm. 2006;3:631.
4. Tsume Y, Amidon GL. The biowaiver extension for BCS class III drugs: the effect of dissolution rate on the bioequivalence of BCS class III immediate-release drugs predicted by computer simulation. Mol Pharm. 2010;7:1235.
5. Kohli K, Chopra S, Dhar D, Arora S, Khar RK. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability. Drug Discov Today. 2010;15:958.
6. Rahman MA, Harwansh R, Mirza MA, Hussain MS, Hussain A. Oral lipid based drug delivery system (LBDDS): formulation, characterization and application: a review. Curr Drug Deliv. 2011;8:330.
7. Kadam Y, Yerramilli U, Bahadur A, Bahadur P. Micelles from PEO-PPO-PEO block copolymers as nanocontainers for solubilization of a poorly water soluble drug hydrochlorothiazide. Colloids Surf B Biointerfaces. 2011;83:49.
8. Kanwar JR, Long BM, Kanwar RK. The use of cyclodextrins nanoparticles for oral delivery. Curr Med Chem. 2011;18:2079.
9. Peltonen L, Hirvonen J. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing, and stabilization methods. J Pharm Pharmacol. 2010;62:1569.
10. Miroshnyk I, Mirza S, Sandler N. Pharmaceutical co-crystals-an opportunity for drug product enhancement. Expert Opin Drug Deliv. 2009;6:333.
11. Janssens S, Van den Mooter G. Review: physical chemistry of solid dispersions. J Pharm Pharmacol. 2009;61:1571.
12. Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev. 2007;59:667.
13. Dubin CH. Formulation strategy for poorly soluble drugs. Drug Del Technol. 2006;6:34.
14. Hussain AS. Quality by Design: Integration of prior knowledge and pharmaceutical development into CMC submission and review: FDA Perspective. AAPS Workshop; 2005.